EOLS

Latest SEC Filings & News for EOLS

2 most recent filings and news items mentioning EOLS. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/EOLS/news?limit=20"

Pull EOLS filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

M&AAug 4, 2026Positive

Evolus Expands Strategic Partnership to Commercialize Estyme in Canada, Australia, and New Zealand

Evolus expanded its partnership with Symatese to gain exclusive rights to commercialize the Estyme injectable HA gel collection in Canada, Australia, and New Zealand, realizing a consistent multi-product platform alongside Jeuveau. This strategic expansion strengthens its interna

View filing at SEC.gov →

M&AJul 8, 2026Positive

Evolus partners with IBSA to launch Profhilo in the U.S.

Evolus entered a deal with IBSA to license Profhilo, a leading European skin quality injectable. This allows the company to expand its portfolio into the fast-growing U.S. aesthetic market.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.